5-carbamoyl-1h-imidazol-4-yl-piperonylate has been researched along with mercaptopurine in 1 studies
| Studies (5-carbamoyl-1h-imidazol-4-yl-piperonylate) | Trials (5-carbamoyl-1h-imidazol-4-yl-piperonylate) | Recent Studies (post-2010) (5-carbamoyl-1h-imidazol-4-yl-piperonylate) | Studies (mercaptopurine) | Trials (mercaptopurine) | Recent Studies (post-2010) (mercaptopurine) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 6,554 | 445 | 1,198 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, M; Inaba, M; Sakurai, Y; Tsukagoshi, S; Yoshida, N | 1 |
1 other study(ies) available for 5-carbamoyl-1h-imidazol-4-yl-piperonylate and mercaptopurine
| Article | Year |
|---|---|
Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Guanosine Monophosphate; Hypoxanthine Phosphoribosyltransferase; Imidazoles; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mercaptopurine; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Purines | 1982 |